252 related articles for article (PubMed ID: 27632954)
1. Epstein-Barr virus latent membrane protein-1 up-regulates cytokines and correlates with older age and poorer prognosis in Hodgkin lymphoma.
Chang KC; Chen PC; Chang Y; Wu YH; Chen YP; Lai CH; Medeiros LJ; Su IJ; Wang HW
Histopathology; 2017 Feb; 70(3):442-455. PubMed ID: 27632954
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
Lin HC; Chang Y; Chen RY; Hung LY; Chen PC; Chen YP; Medeiros LJ; Chiang PM; Chang KC
Cancer Sci; 2021 Apr; 112(4):1589-1602. PubMed ID: 33525055
[TBL] [Abstract][Full Text] [Related]
3. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients.
Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T
APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522
[TBL] [Abstract][Full Text] [Related]
4. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of Epstein-Barr virus (EBV) infection in Hodgkin lymphoma patients.
Myriam BD; Sonia Z; Hanene S; Teheni L; Mounir T
J Infect Chemother; 2017 Mar; 23(3):121-130. PubMed ID: 28034523
[TBL] [Abstract][Full Text] [Related]
6. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
[TBL] [Abstract][Full Text] [Related]
7. Plasma Epstein Barr viral load in adult-onset Hodgkin lymphoma in South India.
Sinha M; Rao CR; Shafiulla M; Shankaranand B; Viveka BK; Lakshmaiah KC; Jacob LA; Babu GK; Jayshree RS
Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):8-13. PubMed ID: 26657995
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated Hodgkin's lymphoma.
Gandhi MK; Tellam JT; Khanna R
Br J Haematol; 2004 May; 125(3):267-81. PubMed ID: 15086409
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus infection induces an increase of T regulatory type 1 cells in Hodgkin lymphoma patients.
Morales O; Mrizak D; François V; Mustapha R; Miroux C; Depil S; Decouvelaere AV; Lionne-Huyghe P; Auriault C; de Launoit Y; Pancré V; Delhem N
Br J Haematol; 2014 Sep; 166(6):875-90. PubMed ID: 25041527
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus as a marker of survival after Hodgkin's lymphoma: a population-based study.
Keegan TH; Glaser SL; Clarke CA; Gulley ML; Craig FE; Digiuseppe JA; Dorfman RF; Mann RB; Ambinder RF
J Clin Oncol; 2005 Oct; 23(30):7604-13. PubMed ID: 16186595
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus encoded latent membrane protein 1 (LMP1) and TNF receptor associated factors (TRAF): colocalisation of LMP1 and TRAF1 in primary EBV infection and in EBV associated Hodgkin lymphoma.
Siegler G; Kremmer E; Gonnella R; Niedobitek G
Mol Pathol; 2003 Jun; 56(3):156-61. PubMed ID: 12782762
[TBL] [Abstract][Full Text] [Related]
12. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
[TBL] [Abstract][Full Text] [Related]
13. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
[TBL] [Abstract][Full Text] [Related]
14. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells.
Baumforth KR; Birgersdotter A; Reynolds GM; Wei W; Kapatai G; Flavell JR; Kalk E; Piper K; Lee S; Machado L; Hadley K; Sundblad A; Sjoberg J; Bjorkholm M; Porwit AA; Yap LF; Teo S; Grundy RG; Young LS; Ernberg I; Woodman CB; Murray PG
Am J Pathol; 2008 Jul; 173(1):195-204. PubMed ID: 18502823
[TBL] [Abstract][Full Text] [Related]
15. Latent membrane protein 1 (LMP1) expression in Hodgkin lymphoma and its correlation with clinical and histologic parameters.
Hashmi AA; Hussain ZF; Hashmi KA; Zafar MI; Edhi MM; Faridi N; Khan M
World J Surg Oncol; 2017 Apr; 15(1):89. PubMed ID: 28427406
[TBL] [Abstract][Full Text] [Related]
16. Impact of the Epstein-Barr virus positivity on Hodgkin's lymphoma in a large cohort from a single institute in Korea.
Koh YW; Yoon DH; Suh C; Huh J
Ann Hematol; 2012 Sep; 91(9):1403-12. PubMed ID: 22526365
[TBL] [Abstract][Full Text] [Related]
17. [Correlation of Epstein-Barr virus infection and childhood lymphoma].
Xie ZD; Wang L; Lu D; Zhou CJ; Shen KL
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):365-7. PubMed ID: 18953837
[TBL] [Abstract][Full Text] [Related]
18. Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's lymphoma.
Claviez A; Tiemann M; Lüders H; Krams M; Parwaresch R; Schellong G; Dörffel W
J Clin Oncol; 2005 Jun; 23(18):4048-56. PubMed ID: 15961758
[TBL] [Abstract][Full Text] [Related]
19. [Clinical characteristics and prognosis analysis of patients with LMP-1 positive Hodgkin's lymphoma after EBV infection].
Ping LY; Ding N; Shi YF; Sun L; Zheng W; Xie Y; Wang XP; Tu MF; Lin NJ; Ying ZT; Liu WP; Deng LJ; Zhan C; Tian L; Feng LX; Song YQ; Zhu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):78-84. PubMed ID: 24598656
[TBL] [Abstract][Full Text] [Related]
20. [Hodgkin's disease and Epstein-Barr virus].
Depil S; Moralès O; Auriault C
Ann Biol Clin (Paris); 2004; 62(6):639-48. PubMed ID: 15563422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]